What's new in pediatric dermatology? Part II. Treatment

Howard B. Pride, Megha Tollefson, Robert Silverman

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

The field of pediatric dermatology has been rich in new developments. Part II of this continuing medical education article will focus on new therapeutic modalities for several entities encountered in pediatric dermatology. The treatment of atopic dermatitis, exciting advances in the use of propranolol and other beta-blockers for the use of infantile hemangiomas, the use of rapamycin for vascular anomalies, the use of biologics in children, the central nervous system risks of general anesthesia in young children, side effects in the use of isotretinoin, the treatment of tinea capitis, treatment of herpes simplex infections, and the use of technologies such as texting and social media in medicine will be discussed.

Original languageEnglish (US)
JournalJournal of the American Academy of Dermatology
Volume68
Issue number6
DOIs
StatePublished - Jun 2013

Fingerprint

Dermatology
Pediatrics
Text Messaging
Tinea Capitis
Social Media
Isotretinoin
Continuing Medical Education
Herpes Simplex
Sirolimus
Atopic Dermatitis
Therapeutics
Hemangioma
Biological Products
Propranolol
General Anesthesia
Blood Vessels
Central Nervous System
Medicine
Technology
Infection

Keywords

  • acne
  • atopic dermatitis
  • eczema herpeticum
  • general anesthesia
  • hemangioma
  • herpes simplex
  • isotretinoin
  • lymphangioma
  • neonatal herpes simplex
  • pediatric dermatology
  • propranolol
  • rapamycin
  • texting
  • tinea capitis
  • vascular malformation

ASJC Scopus subject areas

  • Dermatology

Cite this

What's new in pediatric dermatology? Part II. Treatment. / Pride, Howard B.; Tollefson, Megha; Silverman, Robert.

In: Journal of the American Academy of Dermatology, Vol. 68, No. 6, 06.2013.

Research output: Contribution to journalReview article

@article{cea3afafa5084c9fa07c199bae5e9017,
title = "What's new in pediatric dermatology?: Part II. Treatment",
abstract = "The field of pediatric dermatology has been rich in new developments. Part II of this continuing medical education article will focus on new therapeutic modalities for several entities encountered in pediatric dermatology. The treatment of atopic dermatitis, exciting advances in the use of propranolol and other beta-blockers for the use of infantile hemangiomas, the use of rapamycin for vascular anomalies, the use of biologics in children, the central nervous system risks of general anesthesia in young children, side effects in the use of isotretinoin, the treatment of tinea capitis, treatment of herpes simplex infections, and the use of technologies such as texting and social media in medicine will be discussed.",
keywords = "acne, atopic dermatitis, eczema herpeticum, general anesthesia, hemangioma, herpes simplex, isotretinoin, lymphangioma, neonatal herpes simplex, pediatric dermatology, propranolol, rapamycin, texting, tinea capitis, vascular malformation",
author = "Pride, {Howard B.} and Megha Tollefson and Robert Silverman",
year = "2013",
month = "6",
doi = "10.1016/j.jaad.2013.03.002",
language = "English (US)",
volume = "68",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - What's new in pediatric dermatology?

T2 - Part II. Treatment

AU - Pride, Howard B.

AU - Tollefson, Megha

AU - Silverman, Robert

PY - 2013/6

Y1 - 2013/6

N2 - The field of pediatric dermatology has been rich in new developments. Part II of this continuing medical education article will focus on new therapeutic modalities for several entities encountered in pediatric dermatology. The treatment of atopic dermatitis, exciting advances in the use of propranolol and other beta-blockers for the use of infantile hemangiomas, the use of rapamycin for vascular anomalies, the use of biologics in children, the central nervous system risks of general anesthesia in young children, side effects in the use of isotretinoin, the treatment of tinea capitis, treatment of herpes simplex infections, and the use of technologies such as texting and social media in medicine will be discussed.

AB - The field of pediatric dermatology has been rich in new developments. Part II of this continuing medical education article will focus on new therapeutic modalities for several entities encountered in pediatric dermatology. The treatment of atopic dermatitis, exciting advances in the use of propranolol and other beta-blockers for the use of infantile hemangiomas, the use of rapamycin for vascular anomalies, the use of biologics in children, the central nervous system risks of general anesthesia in young children, side effects in the use of isotretinoin, the treatment of tinea capitis, treatment of herpes simplex infections, and the use of technologies such as texting and social media in medicine will be discussed.

KW - acne

KW - atopic dermatitis

KW - eczema herpeticum

KW - general anesthesia

KW - hemangioma

KW - herpes simplex

KW - isotretinoin

KW - lymphangioma

KW - neonatal herpes simplex

KW - pediatric dermatology

KW - propranolol

KW - rapamycin

KW - texting

KW - tinea capitis

KW - vascular malformation

UR - http://www.scopus.com/inward/record.url?scp=84877812419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877812419&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2013.03.002

DO - 10.1016/j.jaad.2013.03.002

M3 - Review article

C2 - 23680205

AN - SCOPUS:84877812419

VL - 68

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 6

ER -